PRTC (PureTech Health) Cash Flow for Lease Financing : $-3.39 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is PureTech Health Cash Flow for Lease Financing?

PureTech Health's Cash Flow for Lease Financing for the six months ended in Dec. 2024 was $-1.75 Mil. PureTech Health's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 was $-3.39 Mil.

Compared with last quarter ($-1.65 Mil in Jun. 2024 ), PureTech Health's Cash Flow for Lease Financing remained the same in Dec. 2024 ($-1.75 Mil).

PureTech Health Cash Flow for Lease Financing Historical Data

The historical data trend for PureTech Health's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PureTech Health Cash Flow for Lease Financing Chart

PureTech Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Lease Financing

Get a 7-Day Free Trial

-2.91

-3.38

-4.03

-3.34

-3.39

PureTech Health Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash Flow for Lease Financing	Get a 7-Day Free Trial															-2.23	-1.76	-1.57	-1.65	-1.75

PureTech Health Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.

Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-3.39 Mil.

PureTech Health Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of PureTech Health's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

PureTech Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PureTech Health PLC (NAS:PRTC) » Definitions » Cash Flow for Lease Financing

Comparable Companies

Traded in Other Exchanges

PTCHF:USA PRTCl:UK PRTC:UK 0VQ:Germany

Address

6 Tide Street, Suite 400, Boston, MA, USA, 02210

Website

https://www.puretechhealth.com

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.